Markus Hopfer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Markus Hopfer has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Abouzar Hamidipour
EMTensor GmbH
2 shared publications- Ramon Planas
EMTensor GmbH
2 shared publications Serguei Semenov
EMTensor GmbH
2 shared publicationsTommy Henriksson
EMTensor GmbH, Vienna, Austria, Vienna, 1220, Austria
1 shared publication- Tommy Henriksson
EMTensor GmbH, 1220 Vienna, Austria
1 shared publication
Latest Publications
- 11 March 2018
- Published by Springer Nature
- p. 59-86
Electromagnetic Tomography for Brain Imaging and Stroke Diagnostics: Progress Towards Clinical Application
- 11 March 2018
- Published by Springer Nature
- p. 59-86
Electromagnetic Tomography for Brain Imaging and Stroke Diagnostics: Progress Towards Clinical Application
- 24 August 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Antennas and Propagation Magazine
- Vol. 59 (5) , 86-97
Electromagnetic Tomography for Detection, Differentiation, and Monitoring of Brain Stroke: A Virtual Data and Human Head Phantom Study
Brain stroke is one of the leading causes of death and disability worldwide [1]. It can be classified as ischemic stroke (i-stroke), e.g., blood flow is restricted by a blood clot, or hemorrhagic stroke (h-stroke), e.g., a bleeding in the brain. Approximately 80% of total stroke cases are ischemic. The most common treatment for i-stroke to date is the use of thrombolytics: drugs that dissolve the blood clots. The clinical decision to apply a thrombolytic should be made within 3-4.5 h from the onset of the stroke symptoms (e.g., [2]), and it relies on imaging methods such as computed tomography (CT) and magnetic resonance imaging (MRI). Further evaluation of stroke evolution is done mainly by imaging to assess the extent of the ischemic injury and to correlate with the functional behavior of the patient. However, to date there is no accurate way to provide reliable information about the key components of i-stroke physiology that include the position and size of the acute stroke (arterial occlusion), the core infarct region that contains irreversibly injured tissues, and the ischemic penumbra, i.e., the tissue that could potentially be restored by rapid revascularization [1], [3].
- 24 August 2017
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Antennas and Propagation Magazine
- Vol. 59 (5) , 86-97
Electromagnetic Tomography for Detection, Differentiation, and Monitoring of Brain Stroke: A Virtual Data and Human Head Phantom Study
Brain stroke is one of the leading causes of death and disability worldwide [1]. It can be classified as ischemic stroke (i-stroke), e.g., blood flow is restricted by a blood clot, or hemorrhagic stroke (h-stroke), e.g., a bleeding in the brain. Approximately 80% of total stroke cases are ischemic. The most common treatment for i-stroke to date is the use of thrombolytics: drugs that dissolve the blood clots. The clinical decision to apply a thrombolytic should be made within 3-4.5 h from the onset of the stroke symptoms (e.g., [2]), and it relies on imaging methods such as computed tomography (CT) and magnetic resonance imaging (MRI). Further evaluation of stroke evolution is done mainly by imaging to assess the extent of the ischemic injury and to correlate with the functional behavior of the patient. However, to date there is no accurate way to provide reliable information about the key components of i-stroke physiology that include the position and size of the acute stroke (arterial occlusion), the core infarct region that contains irreversibly injured tissues, and the ischemic penumbra, i.e., the tissue that could potentially be restored by rapid revascularization [1], [3].